Vimarsana
Biggest News Aggregation in the World

Page 2 - Man Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Man Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Man Technologies Today - Breaking & Trending Today

Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET - Vimarsana News

Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET

/PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call...

Medicine Man Technologies, Inc. (OTCMKTS:SHWZ) Sees Significant Decrease in Short Interest - Vimarsana News

Medicine Man Technologies, Inc. (OTCMKTS:SHWZ) Sees Significant Decrease in Short Interest

Medicine Man Technologies, Inc. (OTCMKTS:SHWZ – Get Free Report) was the target of a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 1,000 shares, a drop of 44.4% from the March 31st total of 1,800 shares. Based on an average daily trading volume, of […]

Medicine Man Technologies, Inc. (PNK:SHWZ) Q4 2023 Earnings Call Transcript - Vimarsana News

Medicine Man Technologies, Inc. (PNK:SHWZ) Q4 2023 Earnings Call Transcript

Medicine Man Technologies, Inc. misses on earnings expectations. Reported EPS is $-0.43 EPS, expectations were $-0.13. Medicine Man Technologies, Inc.

Schwazze Records 8% Revenue Growth In Q4 2023 Amid Competitive Cannabis Retail Landscape (CORRECTED) - Medicine Man Technologies (OTC:SHWZ) - Vimarsana News

Schwazze Records 8% Revenue Growth In Q4 2023 Amid Competitive Cannabis Retail Landscape (CORRECTED) - Medicine Man Technologies (OTC:SHWZ)

Investment Analysts' Price Target Changes for March 28th (AKBA, ALLY, AROC, ATEC, AXP, AXSM, BAC, BRZE, BWXT, CCL) - Vimarsana News

Investment Analysts' Price Target Changes for March 28th (AKBA, ALLY, AROC, ATEC, AXP, AXSM, BAC, BRZE, BWXT, CCL)

Investment Analysts’ price target changes for Thursday, March 28th: Akebia Therapeutics (NASDAQ:AKBA) had its price target raised by HC Wainwright from $5.00 to $6.00. The firm currently has a buy rating on the stock. Ally Financial (NYSE:ALLY) had its target price increased by Evercore ISI from $41.00 to $43.00. Evercore ISI currently has an in-line […]